Ebola experimental vaccine trial may begin soon in Uganda
Stat, September 30, 2022
Gary Kobinger, an Ebola expert who was involved in the early development of the Merck vaccine, applauded the efforts to use this opportunity to try to add an Ebola Sudan vaccine to the world’s armamentarium against Ebola viruses. “It is great to see WHO leading efforts to have a clinical study evaluating a … vaccine to protect against this deadly pathogen,” said Kobinger, who directs the Galveston National Laboratory at the University of Texas Medical Branch.